CL Stock Recent News
CL LATEST HEADLINES
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) will provide a live video webcast of its 2025 Annual Meeting of Stockholders on Friday, May 9, 2025 at 10:00 a.m. ET. Investors may access the live video webcast at www.virtualshareholdermeeting.com/CL2025. Access will be available beginning at 9:30 a.m. ET. For those unable to participate during the live webcast, a recorded version of the webcast will be made available on the Company's website approximately 24 hours after the meeti.
CL posts better-than-expected first-quarter 2025 results. Results benefited from organic sales growth, robust volume and pricing performance.
Colgate-Palmolive Company reported Q1 results, showing relatively stable underlying sales. The consumer environment remains cautious, causing pressure in some markets and a more cautious underlying outlook. The margin performance was great in Q1. On the other hand, Colgate-Palmolive now sees a $200 million cost impact from tariffs going forward. CL stock is relatively fairly valued. I estimate a fair value of $103.
Colgate-Palmolive Company (NYSE:CL ) Q1 2025 Earnings Conference Call April 25, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer & Executive Vice President, M&A Noel Wallace - Chairman, President & Chief Executive Officer Stan Sutula - Chief Financial Officer Conference Call Participants Peter Grom - UBS Andrea Teixeira - JPMorgan Filippo Falorni - Citi Dara Mohsenian - Morgan Stanley Bonnie Herzog - Goldman Sachs Robert Moskow - TD Cowen Kaumil Gajrawala - Jefferies Robert Ottenstein - Evercore ISI Kevin Grundy - BNP Chris Carey - Wells Fargo Olivia Tong - Raymond James Bryan Spillane - Bank of America Lauren Lieberman - Barclays Korinne Wolfmeyer - Piper Sandler Steve Powers - Deutsche Bank Mark Astrachan - Stifel Operator Good morning. Welcome to today's Colgate-Palmolive 2025 First Quarter Conference Call.
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL 0.36%), a leading manufacturer of consumer products in Oral Care, Personal Care, Home Care, and Pet Nutrition, posted its Q1 2025 earnings on April 25, 2025. However, its GAAP revenue of $4.9 billion decreased 3.1% from Q1 2024, despite exceeding estimates by $45 million.
Colgate-Palmolive Co (NYSE:CL) has cut its full-year earnings outlook, citing the impact of tariffs and currency headwinds, even as it posted first-quarter earnings that topped Wall Street expectations thanks to improved margins. The consumer goods maker now expects full-year organic sales growth of 2% to 4%, down from a prior forecast of 3% to 5%.
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.86 per share a year ago.
Colgate-Palmolive reported quarterly results that beat Wall Street estimates and raised its annual sales forecast on Friday, banking on moderate price hikes and higher advertising spending to boost demand for its oral and personal care products.
Colgate-Palmolive (CL) on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, although it lowered its profit projection.